Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The 3-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past three years. As of today (2026-08-02), Matas AS's 3-Year Sharpe Ratio is 0.15.
Matas AS (CHIX:MATASc) 3-Year Sharpe Ratio Explanation
The 3-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past three years. It is calculated as the annualized result of the average three-year monthly excess returns divided by its standard deviation in the three-year period. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.
The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.
Matas AS 3-Year Sharpe Ratio Related Terms
CHIX:MATASC vs CASY, WSM, ULTA: 3-Year Sharpe Ratio Comparison
For the Specialty Retail subindustry, Matas AS's 3-Year Sharpe Ratio, along with its competitors' market caps and 3-Year Sharpe Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Matas AS 3-Year Sharpe Ratio vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Matas AS's 3-Year Sharpe Ratio distribution charts can be found below:
* The bar in red indicates where Matas AS's 3-Year Sharpe Ratio falls into.
The 3-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset in the last three years. A stock / portfolio's 3-Year Sharpe Ratio can be calculated by dividing the difference between the three-year average monthly returns of the investment and the risk-free rate, by the standard deviation of the investment returns over the past three years.
Matas AS (CHIX:MATASC) has a 3-Year Sharpe Ratio of 0.15 as of Aug. 02, 2026. 3-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past three years. View historical data for Matas AS and its competitors.
Is Matas AS's 3-Year Sharpe Ratio too high?
Matas AS's current 3-Year Sharpe Ratio is 0.15. Overall, Matas AS has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Matas AS's 3-Year Sharpe Ratio compare to CASY and WSM?
Matas AS's 3-Year Sharpe Ratio of 0.15 can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Sharpe Ratio for a Retail - Cyclical company?
A good 3-Year Sharpe Ratio depends on the Retail - Cyclical industry context. However, 3-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Sharpe Ratio mean?
A high 3-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 3-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past three years. View historical data for Matas AS and its competitors. Matas AS's current 3-Year Sharpe Ratio is 0.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Matas AS stock overvalued right now?
Matas AS (CHIX:MATASC) has a current 3-Year Sharpe Ratio of 0.15. The stock's GF Value™ is kr178.66, compared to a current price of kr100.70 — trading 43.6% below its estimated fair value. The current 3-Year Sharpe Ratio is 0.15. Matas AS's overall GF Score™ is 84/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Sharpe Ratio calculated?
3-Year Sharpe Ratio is calculated from a company's financial statements. For Matas AS (CHIX:MATASC), the current 3-Year Sharpe Ratio is 0.15 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Matas AS (CHIX:MATASC) Overvalued in 2026?
Based on GuruFocus' analysis, Matas AS stock appears to be undervalued.
The current stock price of kr100.70 is trading 43.6% below its estimated GF Value™ of kr178.66.
Key valuation signals for CHIX:MATASC:
3-Year Sharpe Ratio: 0.15
GF Value™: kr178.66 vs. price of kr100.70 (43.6% below fair value)
No single metric tells the full story. See the CHIX:MATASC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Matas AS is beauty and wellbeing brands. It has three segments Matas, KICKS and Other. It generates majority of revenue from Matas segment. Its product groups are High-end Beauty: Luxury beauty products, including cosmetics, skincare and haircare products and fragrances; Mass Beauty: Everyday beauty products and personal care, including cosmetics and skincare and haircare products; Health and Wellbeing: MediCare Vitamins, minerals, health supplements, specialty foods and herbal medicinal products. Sports, nutrition and exercise. Baby and parent. Sexual wellness, Personal care products and special skincare; Other: Clothing and accessories. It generates majority of revenue from Denmark followed by Sweden, Norway, and Other countries.
84GF Score
Get the complete analysis for CHIX:MATASC
3-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:MATASC has been successfully added to your 
